Stonehaven Bio
All research guides

Peptide research

GLP-1R

GLP-1R is an advanced research-grade peptide classified as a triple receptor agonist (GGG), designed for investigative work in metabolic and obesity-related research models.

01 / Overview

Understanding GLP-1R

GLP-1R is an advanced research-grade peptide classified as a triple receptor agonist (GGG), designed for investigative work in metabolic and obesity-related research models. Unlike traditional GLP-1 receptor agonists that primarily target a single pathway, GLP-1R engages three distinct receptors: GLP-1, GIP, and glucagon, providing a broader framework for studying metabolic signaling interactions.

In research settings, GLP-1 and GIP receptor activity has been associated with delayed gastric emptying, appetite signaling modulation, and regulation of energy intake. GLP-1R’s distinguishing feature is its additional interaction with the glucagon receptor, which has been examined in preclinical research for its role in energy mobilization, lipid utilization, and glycogen metabolism. This multi-receptor engagement allows researchers to explore metabolic processes beyond those addressed by earlier GLP-1–based compounds.

By combining incretin-related pathways with glucagon receptor signaling, GLP-1R offers a next-generation investigational peptide for studying complex metabolic balance, energy expenditure mechanisms, and body-weight regulation models. Its tri-agonist profile makes it a valuable tool for laboratory research focused on metabolic regulation and signaling pathway integration.

This product is supplied strictly for laboratory research purposes only.

Not for human consumption, clinical use, or veterinary application. Further research is required to fully evaluate its characteristics and long-term biological interactions.

Technical details

Composition, characteristics, and laboratory context.

Peptide Name
GLP-1R
Content
10 mg per vial
Peptide Class
Triple receptor agonist (GLP-1 / GIP / Glucagon)
Research Focus Areas
  • Metabolic signaling pathways
  • Energy balance and utilization models
  • Appetite regulation mechanisms
  • Incretin and glucagon receptor interaction studies
Receptor Activity (Research Context)
  • GLP-1 receptor: Studied for its role in gastric emptying delay and appetite signaling
  • GIP receptor: Investigated in metabolic modulation and nutrient response pathways
  • Glucagon receptor: Examined for effects on energy mobilization, lipid metabolism, and glycogen utilization
Form
Lyophilized peptide
Purity
≥98% (HPLC) (if applicable—can be adjusted)
Storage
Store frozen at recommended laboratory temperatures; protect from light and moisture
Handling
For qualified laboratory personnel only
Regulatory Status
  • Research Use Only (RUO)
  • Not approved for human or animal use
  • Not intended to diagnose, treat, cure, or prevent any disease

Research at a glance

FeatureTraditional GLP-1 Research PeptidesDual GLP-1 / GIP Research PeptidesGLP-1R (Tri-Agonist)
Receptor TargetsGLP-1GLP-1, GIPGLP-1, GIP, Glucagon
Pathway ScopeSingle incretin pathwayDual incretin pathwaysIntegrated metabolic pathways
Appetite Signaling ResearchYesYesYes
Energy Utilization ResearchLimitedModerateExpanded (includes glucagon signaling)
Metabolic Signaling ComplexityLowModerateHigh
Research FocusAppetite & gastric signalingEnhanced metabolic modulationEnergy balance & metabolic integration
Intended UseLaboratory researchLaboratory researchLaboratory research only

Important: This comparison reflects structural and receptor-target differences only and does not suggest superiority, safety, or effectiveness.

Questions, answered.

What is GLP-1R?

GLP-1R is an investigational tri-agonist peptide developed for research into metabolic signaling pathways. Unlike single-pathway peptides, it interacts with three receptors—GLP-1, GIP, and glucagon—allowing researchers to explore more complex metabolic mechanisms.

What does “tri-agonist” mean in peptide research?

A tri-agonist peptide is designed to activate three distinct biological receptors. In research contexts, this enables simultaneous study of multiple signaling pathways involved in appetite regulation, energy utilization, and metabolic balance.

How is GLP-1R different from older GLP-1 research peptides?

Traditional GLP-1 research peptides primarily focus on incretin signaling and appetite modulation. GLP-1R expands on this framework by also engaging the glucagon receptor, which is studied for its role in energy mobilization and metabolic activity. This broader receptor engagement allows researchers to investigate integrated metabolic responses, rather than isolated pathways, within experimental models. (This comparison is provided for research context only and does not imply superiority or clinical outcomes.)

Is GLP-1R approved for medical or clinical use?

No. GLP-1R is supplied strictly for laboratory research purposes. It is not approved for human consumption, clinical trials, diagnostic use, or veterinary applications.

Who should handle this peptide?

This product is intended for qualified researchers and laboratory professionals conducting controlled experimental work. Proper laboratory handling, storage, and documentation procedures should be followed at all times.

How should GLP-1R be stored?

GLP-1R is provided in lyophilized form and should be stored under recommended laboratory conditions, typically frozen and protected from light and moisture, to maintain stability.

Research use only

These products are intended strictly for laboratory research purposes. They are not for human consumption, clinical use, diagnostic use, or veterinary application. These products are not approved by any regulatory authority for medical use and are not intended to diagnose, treat, cure, or prevent any disease. All information provided is for educational and research reference purposes only. Proper laboratory handling procedures must be followed. The purchaser assumes full responsibility for the appropriate use, storage, and handling of this material.